CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,207 shares (to pay taxes)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $33.20 ($67,529)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $33.40 ($300,560)
- 4 Shares withheld for taxes Director gave up 901 shares (to pay taxes)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $34.57 ($70,315)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $35.51 ($319,604)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale VP, Finance (Interim PAO) sold 6,890 shares at $29.29 ($201,808)
- 4 Planned sale SVP, Chief Commercial Officer sold 6,000 shares at $30.00 ($180,000)
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $29.72 ($267,485)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 4,068 shares at an average $29.53 ($120,108)
Page 2 of 67 · 1,323 filings